Search results
The AncestryDNA Genetic Testing Kit Is Under $40 On Amazon, If You're Curious
HuffPost· 2 days agoThis AncestryDNA testing kit is at its lowest price ever. The advent of at-home DNA tests has made...
U.S. Senate Republicans reject Democrats’ bill on IVF protections
Nebraska Examiner via Yahoo News· 11 hours agoWASHINGTON — U.S. Senate Democrats’ attempts to bolster reproductive rights failed again Thursday...
A New Bird Flu Death Is Making Experts Uneasy
Time via Yahoo News· 7 days agoThe infection was fatal. The case was first reported to the WHO on May 23 by health officials in Mexico City, where a 59-year-old man with several other...
Could AI & a Blood Test Help Spot Lung Cancers Early? | FOX 28 Spokane
FOX 28 Spokane· 4 days agoResearchers have shown that artificial intelligence (AI) can identify people who are at risk for...
Parents fight back after learning state keeps their babies’ blood for 23 years without telling them
The Independent via Yahoo News· 3 days agoLike every other US state, New Jersey requires all hospitals to take a pinprick of blood from every...
State Insists It Can Keep Babies’ Blood Without Parental Consent
Forbes· 4 days agoEvery state in the U.S. requires hospitals to take a small blood sample from newborns to test for ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoSo, MRNA stock ranks narrowly inside the top half of all stocks, regardless the industry group, on...
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application...
Morningstar· 4 days agoTOKYO and CAMBRIDGE, Mass., June 09, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”)
Never Give Up and Always Keep the Faith—90 Quotes About Breast Cancer That Resonate
Parade via Yahoo News· 16 hours ago"Don’t delegate your survival to the doctors and hope for the best. You have to participate in your...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 4 days agoBecause certain genetic mutations to TYK2 have been associated with a protective effect in multiple...